J.H. Whitney Equity Partners VII, LLC - Oct 24, 2025 Form 4 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)

Role: 10%+ Owner
Signature: /s/ David Zatlukal, Attorney-in-Fact
Stock symbol: AVAH
Transactions as of: Oct 24, 2025
Transactions value $: -$11,267,181
Form type: 4
Date filed: 10/28/2025, 04:15 PM
Previous filing: Oct 23, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
J.H. Whitney Equity Partners VII, LLC	10%+ Owner	212 ELM STREET, NEW CANAAN	/s/ David Zatlukal, Attorney-in-Fact	2025-10-28	0001567459

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVAH	Common Stock, $0.01 par value	Sale	-$11.3M	-1.25M	-6.09%	$9.00	19.3M	Oct 24, 2025	By J.H. Whitney VII, L.P.	F1, F2
holding	AVAH	Common Stock, $0.01 par value						0	Oct 24, 2025	Direct	F1
holding	AVAH	Common Stock, $0.01 par value						15.5M	Oct 24, 2025	By PSA Healthcare Investment Holdings LLC	F1
holding	AVAH	Common Stock, $0.01 par value						1.43M	Oct 24, 2025	By PSA Iliad Holdings LLC	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
F2	On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.

Content

J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

On October 24, 2025, J.H. Whitney VII, L.P sold 1,251,909 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.